[Ip-health] 'DIE IN' PROTEST AGAINST THE EU-INDIA FTA NEGOTIATIONS BY DELHI BETWORK OF POSITIVE PEOPLE
leena.menghaney at geneva.msf.org
Tue Oct 5 05:41:51 PDT 2010
INDIA'S CENTRAL ROLE IN MEDICINES SUPPLY IS UNDER THREAT: 'DIE IN' PROTEST
AGAINST THE EU-INDIA FREE TRADE AGREEMENT
11.00 - 12:30 a.m., Wednesday, 6th October 2010
Udyog Bhawan (Ministry of Commerce), New Delhi
Delhi Network of Positive People (DNP+) is holding a demonstration by
staging a mass 'Die In' in front of Udyog Bhawan (Ministry of Commerce)to
protest against the inclusion of intellectual property (IP) provisions in
the EU-India FTA. A crucial round of negotiations between India and
European Commission on intellectual property provisions will take place on
6-8 October 2010 at Udyog Bhawan, New Delhi. The EU-India FTA negotiations
are set to be concluded before the end of 2010.
Four million people started AIDS treatment between 2003 and 2008, due to
largely India's ability to produce low-cost quality medicines. The EU India
trade and investment agreement being currently negotiated may further reduce
India's vital role as provider of life-saving treatments.
Already with the introduction of the product patent regime in 2005, Indian
generic companies cannot produce and supply new HIV medicines that will be
needed soon for patients failing second line Antiretroviral Therapy. The
reason -increasing number of patent barriers in India.
The EU-India FTA if concluded without removing the IP provisions will make
it worse as it intends to prolong patent terms by a number of years, makes
registration of off patent generic medicines difficult, seeks to undermine
the Indian judiciary's role of protecting patients, and finally tries to
legalise EU's border measures that led to the confiscation of life-saving
generic medicines in transit to developing countries.
The 'Die In' protest is being organized to emphasize the grave danger that
countless human lives in developing countries face if the FTA is finalized
without removing the IP provisions.
For information please contact:
Shailly Gupta @+91 9899976108
More information about the Ip-health